Acasti制药 ACST 深 沪
等待开盘 09-18 09:30:00 美东时间
3.37
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 3.37
- 总市值 3167.60万
- 52周最高 3.60
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.98
- 委 比 0.00%
- 总股本 939.94万
- 历史最高 2016.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.98
- 每 手 1
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AgEagle Aerial Systems MicaSense Series RedEdge-P Multispectral Camera Available Now on Ascent’s SPIRIT™ and SPARTAN™ UAV Platforms
AgEagle and Ascent AeroSystems have successfully integrated the MicaSense RedEdge-P multispectral camera with Ascent's SPIRIT and SPARTAN UAV platforms, enhancing agricultural and environmental monitoring capabilities. The combination of high-resolution imaging and rugged, all-weather hardware provides advanced solutions for precision agriculture and research applications.
09-04 12:00
Grace Therapeutics Reports Promising Drug Development Progress
Acasti Pharma, Inc. ( ($GRCE) ) has released its Q4 earnings. Here is a breakdo...
06-24 11:52
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
Oral presentation to highlight preclinical investigation of Claudin-6 ADC in ovarian and NSCLC cancer models Preclinical data for PSMA and ASCT2-targeted ADCs accepted for poster presentatio...
03-26 05:30
Grace therapeutics announces private placement financing of $30 million
Grace Therapeutics (NASDAQ:GRCE), formerly Acasti Pharma, on Monday said it has signed securities purchase agreements with new and existing healthcare focused institutional investors to raise up to ap...
02-10 21:15
Acasti Pharma changes name to Grace Therapeutics
Acasti Pharma announced that it is changing its name to Grace Therapeutics. Grace Therapeutics was the name of the company developing GTx-104 prior to its merger with Acasti in 2021. Grace Therapeutic...
2024-10-25 20:57
Acasti Pharma’s Strategic Moves and Shareholder Decisions
Acasti Pharma ( ($ACST) ) has shared an announcement. At a recent shareholder m...
2024-10-01 04:57
快讯 | acasti pharma: 预计在2024年底至2025年初将100名患者进行随机分组
Acasti Pharma Inc: Anticipate Randomizing All 100 Patients in Late 2024 to Earl...
2024-06-28 04:07
快讯 | Acasti Pharma公司：预计在2025年上半年按照日历时间表向FDA提交潜在的NDA申请。
Acasti Pharma Inc: Anticipate Staying on Track for a Potential Nda Submission t...
2024-06-28 04:07
快讯 | Acasti宣布至关重要的第三阶段试验“Strive-on Safety Trial”已经招募50%的人数。
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 Strive-on Saf...
2024-06-28 04:05
Acasti Pharma GAAP EPS of -$1.35
Acasti Pharma press release (NASDAQ:ACST): FY GAAP EPS of -$1.35. At March 31, 2024, the Company had cash and cash equivalents of $23.0 million, as compared to $27.9 million as of March 31, 2023. The ...
2024-06-21 21:17
